More on ALC
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $66.58 |
|
|||
| Open | $66.95 | ||||
| 52 Wk High | $14.66 | ||||
| 52 Wk Low | $6.93 | ||||
| Day High | $67.02 | ||||
| Day Low | $66.04 | ||||
| P/E | N/A | ||||
| EPS | $-1.75 | ||||
| Volume | 1,454,880 | ||||
- FDA approves Alcon eye drops for up to 12 hours of redness relief
- FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Increasing unusual option volume: JBS CCC AIPO INDA CMBT ERIC ALC
- Algoma Central Corporation Increases Quarterly Dividend and Declares Special Dividend
- Barclays Starts Alcon Inc. (ALC) at Equalweight
- Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
- Alcon launches Unity M ophthalmic microscope in U.S. and Japan
- Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
- Alcon prices €500M senior notes due 2033
- Alcon Prices EUR 500 Million Senior Notes Offering
Entities mentioned with ALC
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Alcon Acquired by Novartis | View Related Stories »
- FDA | View Related Stories »
- Show More...
